Second Sight eyes $25M funding round | Wall Street Beat

January 29, 2013 by MassDevice staff

Second Sight Medical registers for a $25 million funding round as it awaits the FDA's decision on its Argus II "bionic eye" retinal implant. Wall Street Beat

Second Sight Medical registered with the SEC for a $25 million offering of equity, debt, options and warrants as it waits for the FDA to decide whether to give the green light to its "bionic eye" retinal implant.

The Sylmar, Calif.-based medical device company filed with the securities watchdog agency yesterday, saying it has yet to sell any of the $1,000 shares in the offering.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.